Skip to main content

Table 1 The drug resistance of all bacteria involved in the study

From: Effect on 30-day mortality and duration of hospitalization of empirical antibiotic therapy in CRGNB-infected pneumonia

Antibiotics Drug resistance rate
Acinetobacter baumannii Klebsiella pneumoniae (%) Pseudomonas aeruginosa
Ampicillin / 100.00 /
Ampicillin/sulbactam 94.50% 100.00 /
Nitrofurantoin / 96.55 /
Compound sulfamethoxazole 72.86% 47.50 /
Ciprofloxacin 91.90% 73.91 50.00%
Piperacillin/tazobactam 88.68% 67.39 39.13%
Gentamicin 75.24% 67.39 40.82%
Cefepime 94.29% 84.78 42.31%
Ceftriaxone 95.24% 97.50 /
Ceftazidime 94.76% 89.13 55.10%
Cefotetan / 100.00 /
Cefoxitin / 100.00 /
Tobramycin 70.81% 65.22 43.14%
Cefuroxime / 100.00 /
Tigecycline 2.99% 3.85 /
Cefoperazone/sulbactam / 73.33 /
Levofloxacin 48.80% 71.74 38.46%
Cefotaxime 95.83% 96.15 /
Minocycline 7.88% 0.00 /
Cefmetazole / 75.00 /
Piperacillin 97.67% 76.92 43.48%
Cefazolin / 100.00 /
Amikacin 57.67% 63.04 22.00%
Polymyxin 0.60% 0.00 3.33%
Aztreonam / 97.67 75.00%
\